Key Points
- Director Thomas Kosasa purchased 129,758 OneMedNet shares at an average price of $5.78, investing approximately $750,001 and increasing his ownership by 7% to 1,983,573 shares.
- OneMedNet shares opened at $4.02, compared with a 12-month range of $3.61 to $32.00; the stock’s 50-day and 200-day moving averages were $6.10 and $7.25, respectively.
- Analyst sentiment remains negative: One analyst rates the stock “Sell,” and Weiss Ratings recently upgraded it only from “sell (e+)” to “sell (d-).”
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) CFO Robert Golden sold 2,500 shares of the firm's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $6.60, for a total transaction of $16,500.00. Following the completion of the transaction, the chief financial officer directly owned 97,291 shares of the company's stock, valued at approximately $642,120.60. This trade represents a 2.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Robert Lawrence Golden also recently made the following trade(s):
- On Monday, September 21st, Robert Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.63, for a total transaction of $19,890.00.
- On Tuesday, September 15th, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.30, for a total transaction of $18,900.00.
OneMedNet Price Performance
Shares of NASDAQ:ONMD opened at $4.02 on Wednesday. The company's 50-day moving average price is $6.10 and its two-hundred day moving average price is $7.25. OneMedNet Corporation has a one year low of $3.61 and a one year high of $32.00.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded OneMedNet from a "sell (e+)" rating to a "sell (d-)" rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, OneMedNet has an average rating of "Sell".
View Our Latest Report on ONMD
OneMedNet Company Profile
(
Get Free Report)
OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.
The company's technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
